Jeff Johnson
Stock Analyst at Baird
(2.13)
# 729
Out of 5,320 analysts
156
Total ratings
52.08%
Success rate
21.66%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
COO Cooper Companies | Maintains: Outperform | 117 107 | 78.74 | 35.89% | 16 | Mar 7, 2025 | |
TNDM Tandem Diabetes Care | Maintains: Neutral | 37 33 | 16.41 | 101.1% | 15 | Feb 27, 2025 | |
ALC Alcon | Maintains: Outperform | 104 108 | 91.42 | 18.14% | 9 | Feb 27, 2025 | |
DXCM DexCom | Upgrades: Outperform | 86 104 | 66.11 | 57.31% | 13 | Jan 16, 2025 | |
PDCO Patterson Cos | Maintains: Neutral | 25 31 | 31.33 | -1.05% | 7 | Dec 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 22 | 14.88 | 47.85% | 7 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 378 405 | 339.88 | 19.16% | 11 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 325 276 | 171.66 | 60.78% | 16 | Oct 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 145 | 96.38 | 50.45% | 13 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 92 82 | 63.11 | 29.93% | 9 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 180 238 | 238.61 | -0.26% | 12 | Dec 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 70 | 32.2 | 117.39% | 2 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 53 61 | 14.81 | 311.88% | 4 | Jul 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 67 | 12.81 | 423.03% | 6 | Feb 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 | 39.75 | 40.88% | 7 | Oct 30, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 178 | n/a | n/a | 6 | Oct 28, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 31 | n/a | n/a | 3 | Nov 11, 2019 |